Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways

Renal fibrosis is considered as the pathway of almost all kinds of chronic kidney diseases (CKD) to the end stage of renal diseases (ESRD). Ganoderic acid (GA) is a group of lanostane triterpenes isolated from Ganoderma lucidum, which has shown a variety of pharmacological activities. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Xiao-qiang, Ma, Ang, He, Jin-zhao, Wang, Liang, Jia, Ying-li, Shao, Guang-ying, Li, Min, Zhou, Hong, Lin, Shu-qian, Ran, Jian-hua, Yang, Bao-xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468553/
https://www.ncbi.nlm.nih.gov/pubmed/31804606
http://dx.doi.org/10.1038/s41401-019-0324-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468553/
https://www.ncbi.nlm.nih.gov/pubmed/31804606
http://dx.doi.org/10.1038/s41401-019-0324-7

Ejemplares similares